TEST BANK
Abrams' Clinical Drug Therapy: Rationales for
Nursing Practice Thirteenth, North American
Edition
by Geralyn Frandsen EdD RN (Author), SANDRA PENNINGTON (Author)
, TABLE OF CONTENTS
Section 1: The Conceptual Framework of Pharmacology
o Chapter 1: The Foundation of Pharmacology: Quality and Safety
o Chapter 2: Basic Concepts and Processes
o Chapter 3: Medication Administration and the Nursing Process of Drug Therapy
Section 2: Drug Therapy Throughout the LifespanChapter 4: Pharmacology and the
Care of Infants and Pediatric Patients
o Chapter 5: Pharmacology and the Care of Adults and Geriatric Patients
o Chapter 6: Pharmacology and the Care of Pregnant or Lactating Females
o Chapter 7: Pharmacology and Female Health
o Chapter 8: Pharmacology and Male Health
Section 3: Drugs Affecting the Hematopoietic and Immune Systems
o Chapter 9: Drug Therapy for Coagulation Disorders
o Chapter 10: Drug Therapy for Dyslipidemia
o Chapter 11: Drug Therapy for Hematopoietic Disorders
o Chapter 12: Drug Therapy: Immunizations
o Chapter 13: Drug Therapy to Decrease Immunity
o Chapter 14: Drug Therapy for the Treatment of Cancer
Section 4: Drugs Affecting Inflammation and Infection
o Chapter 15: Inflammation, Infection, and the Use of Antimicrobial Agents
o Chapter 16: Drug Therapy to Decrease Pain, Fever, and Inflammation
o Chapter 17: Drug Therapy with Corticosteroids
o Chapter 18: Drug Therapy with Beta-Lactam Antibacterial Agents
o Chapter 19: Drug Therapy with Aminoglycosides and Fluoroquinolones
o Chapter 20: Drug Therapy with Tetracyclines, Sulfonamides, and Urinary
Antiseptics
o Chapter 21: Drug Therapy with Macrolides and Miscellaneous Anti -Infective Agents
o Chapter 22: Drug Therapy for Tuberculosis and Mycobacterium avium Complex
Disease
o Chapter 23: Drug Therapy for Viral Infections
o Chapter 24: Drug Therapy for Fungal Infections
o Chapter 25: Drug Therapy for Parasitic Infections
Section 5: Drug Affecting the Cardiovascular System
o Chapter 26: Drug Therapy for Hypertension
o Chapter 27: Drug Therapy for Dysrhythmias
o Chapter 28: Drug Therapy for Coronary Heart Disease
o Chapter 29: Drug Therapy for Shock and Hypotension
o Chapter 30: Drug Therapy for Heart Failure
Section 6: Drugs Affecting the Respiratory System
o Chapter 31: Drug Therapy for Nasal Congestion and Cough
o Chapter 32: Drug Therapy to Decrease Histamine Effects and Allergic Response
o Chapter 33: Drug Therapy for Asthma, Airway Inflammation, and
Bronchoconstriction
, Section 7: Drugs Affecting the Renal and Digestive Systems
o Chapter 34: Drug Therapy for Fluid Volume Excess
o Chapter 35: Nutritional Support Products, Vitamins, and Mineral Supplements
o Chapter 36: Drug Therapy for Weight Management
o Chapter 37: Drug Therapy for Peptic Ulcer Disease and Hyperacidity
o Chapter 38: Drug Therapy for Nausea and Vomiting
o Chapter 39: Drug Therapy for Constipation and Elimination Problems
o Chapter 40: Drug Therapy for Diarrhea
Section 8: Drugs Affecting the Endocrine System
o Chapter 41: Drug Therapy for Diabetes Mellitus
o Chapter 42: Drug Therapy for Hyperthyroidism and Hypothyroidism
o Chapter 43: Drug Therapy for Pituitary and Hypothalamic Dysfunction
o Chapter 44: Drug Therapy to Regulate Calcium and Bone Metabolism
o Chapter 45: Drug Therapy for Adrenal Cortex Disorders
Section 9: Drugs Affecting the Autonomic and Central Nervous System
o Chapter 46: Physiology of the Autonomic and Central Nervous Systems and
Indications for the Use of Drug Therapy
o Chapter 47: Drug Therapy for Myasthenia Gravis, Alzheimer Disease, and Other
Conditions Treated with Cholinergic Agents
o Chapter 48: Drug Therapy for Parkinson Disease, Urinary Spasticity, and Disorders
Requiring Anticholinergic Drug Therapy
o Chapter 49: Drug Therapy with Opioids
o Chapter 50: Drug Therapy with Local Anesthetics
o Chapter 51: Drug Therapy with General Anesthetics
o Chapter 52: Drug Therapy for Migraines and Other Headaches
o Chapter 53: Drug Therapy for Seizure Disorders and Skeletal Muscle Disorders
o Chapter 54: Drug Therapy for Anxiety and Insomnia
o Chapter 55: Antidepressants and Mood Stabilizers
o Chapter 56: Drug Therapy for Psychotic Disorders
o Chapter 57: Drug Therapy for Attention-Deficit/Hyperactivity Disorder and
Narcolepsy
o Chapter 58: Drug Therapy for Substance Use Disorders
Section 10: Drugs Affecting the Eye, Ear, and Skin
o Chapter 59: Drug Therapy for Disorders of the Eye
o Chapter 60: Drug Therapy for Disorders of the Ear
o Chapter 61: Drug Therapy for Disorders of the Skin
, Abrams’ Clinical Drug Therapy Rationales For Nursing Practice 13th
Edition Geralyn Frandsen - ISBN/ISSN 9781975136130
Chapter 1, The Foundation Of Pharmacology: Quality And Safety
1. A Woman Diagnosed With Obsessive–Compulsive Disorder Has Been Prescribed Oral
Paroxetine Hydrochloride. What Is The Expected Effect For This Prescription?
A. Curative Effect On Symptoms
B. Systemic Effect On Symptoms
C. Local Effect On Symptoms
D. Parenteral Effect On Symptoms
ANSWER; B
Rationale: Drugs That Produce Systemic Effects Are Taken Into The Body, Circulated Through
The Bloodstream To Their Sites Of Action In Various Body Tissues, And Eventually Eliminated
From The Body. Curative Agents Are Given To Cure A Disease Process. In This Case, Paroxetine
Hydrochloride Will Control The Symptoms But Not Cure The Disorder. Drugs With Local Effects,
Such As Sunscreen And Local Anesthetics, Act Mainly At The Site Of Application. Paroxetine
Hydrochloride Is Not Administered Parenterally. Parenteral Agents Are Administered
Subcutaneously, Intramuscularly, Or Intravenously.
PTS: 1 REF: P. 3, Introduction OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological And Parenteral Therapies TOP:
Chapter: 1: The Foundation Of Pharmacology: Quality And Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
2. A Client Has Been Prescribed An Antibiotic. This Medication Is A Naturally Occurring
Substance That Has Been Chegmricaaldlyemsobdoifoiesd.TW.Hcaot Mis Another Name For This
Type Of Medication?
A. Synthetic Drug
B. Semisynthetic Drug
Abrams' Clinical Drug Therapy: Rationales for
Nursing Practice Thirteenth, North American
Edition
by Geralyn Frandsen EdD RN (Author), SANDRA PENNINGTON (Author)
, TABLE OF CONTENTS
Section 1: The Conceptual Framework of Pharmacology
o Chapter 1: The Foundation of Pharmacology: Quality and Safety
o Chapter 2: Basic Concepts and Processes
o Chapter 3: Medication Administration and the Nursing Process of Drug Therapy
Section 2: Drug Therapy Throughout the LifespanChapter 4: Pharmacology and the
Care of Infants and Pediatric Patients
o Chapter 5: Pharmacology and the Care of Adults and Geriatric Patients
o Chapter 6: Pharmacology and the Care of Pregnant or Lactating Females
o Chapter 7: Pharmacology and Female Health
o Chapter 8: Pharmacology and Male Health
Section 3: Drugs Affecting the Hematopoietic and Immune Systems
o Chapter 9: Drug Therapy for Coagulation Disorders
o Chapter 10: Drug Therapy for Dyslipidemia
o Chapter 11: Drug Therapy for Hematopoietic Disorders
o Chapter 12: Drug Therapy: Immunizations
o Chapter 13: Drug Therapy to Decrease Immunity
o Chapter 14: Drug Therapy for the Treatment of Cancer
Section 4: Drugs Affecting Inflammation and Infection
o Chapter 15: Inflammation, Infection, and the Use of Antimicrobial Agents
o Chapter 16: Drug Therapy to Decrease Pain, Fever, and Inflammation
o Chapter 17: Drug Therapy with Corticosteroids
o Chapter 18: Drug Therapy with Beta-Lactam Antibacterial Agents
o Chapter 19: Drug Therapy with Aminoglycosides and Fluoroquinolones
o Chapter 20: Drug Therapy with Tetracyclines, Sulfonamides, and Urinary
Antiseptics
o Chapter 21: Drug Therapy with Macrolides and Miscellaneous Anti -Infective Agents
o Chapter 22: Drug Therapy for Tuberculosis and Mycobacterium avium Complex
Disease
o Chapter 23: Drug Therapy for Viral Infections
o Chapter 24: Drug Therapy for Fungal Infections
o Chapter 25: Drug Therapy for Parasitic Infections
Section 5: Drug Affecting the Cardiovascular System
o Chapter 26: Drug Therapy for Hypertension
o Chapter 27: Drug Therapy for Dysrhythmias
o Chapter 28: Drug Therapy for Coronary Heart Disease
o Chapter 29: Drug Therapy for Shock and Hypotension
o Chapter 30: Drug Therapy for Heart Failure
Section 6: Drugs Affecting the Respiratory System
o Chapter 31: Drug Therapy for Nasal Congestion and Cough
o Chapter 32: Drug Therapy to Decrease Histamine Effects and Allergic Response
o Chapter 33: Drug Therapy for Asthma, Airway Inflammation, and
Bronchoconstriction
, Section 7: Drugs Affecting the Renal and Digestive Systems
o Chapter 34: Drug Therapy for Fluid Volume Excess
o Chapter 35: Nutritional Support Products, Vitamins, and Mineral Supplements
o Chapter 36: Drug Therapy for Weight Management
o Chapter 37: Drug Therapy for Peptic Ulcer Disease and Hyperacidity
o Chapter 38: Drug Therapy for Nausea and Vomiting
o Chapter 39: Drug Therapy for Constipation and Elimination Problems
o Chapter 40: Drug Therapy for Diarrhea
Section 8: Drugs Affecting the Endocrine System
o Chapter 41: Drug Therapy for Diabetes Mellitus
o Chapter 42: Drug Therapy for Hyperthyroidism and Hypothyroidism
o Chapter 43: Drug Therapy for Pituitary and Hypothalamic Dysfunction
o Chapter 44: Drug Therapy to Regulate Calcium and Bone Metabolism
o Chapter 45: Drug Therapy for Adrenal Cortex Disorders
Section 9: Drugs Affecting the Autonomic and Central Nervous System
o Chapter 46: Physiology of the Autonomic and Central Nervous Systems and
Indications for the Use of Drug Therapy
o Chapter 47: Drug Therapy for Myasthenia Gravis, Alzheimer Disease, and Other
Conditions Treated with Cholinergic Agents
o Chapter 48: Drug Therapy for Parkinson Disease, Urinary Spasticity, and Disorders
Requiring Anticholinergic Drug Therapy
o Chapter 49: Drug Therapy with Opioids
o Chapter 50: Drug Therapy with Local Anesthetics
o Chapter 51: Drug Therapy with General Anesthetics
o Chapter 52: Drug Therapy for Migraines and Other Headaches
o Chapter 53: Drug Therapy for Seizure Disorders and Skeletal Muscle Disorders
o Chapter 54: Drug Therapy for Anxiety and Insomnia
o Chapter 55: Antidepressants and Mood Stabilizers
o Chapter 56: Drug Therapy for Psychotic Disorders
o Chapter 57: Drug Therapy for Attention-Deficit/Hyperactivity Disorder and
Narcolepsy
o Chapter 58: Drug Therapy for Substance Use Disorders
Section 10: Drugs Affecting the Eye, Ear, and Skin
o Chapter 59: Drug Therapy for Disorders of the Eye
o Chapter 60: Drug Therapy for Disorders of the Ear
o Chapter 61: Drug Therapy for Disorders of the Skin
, Abrams’ Clinical Drug Therapy Rationales For Nursing Practice 13th
Edition Geralyn Frandsen - ISBN/ISSN 9781975136130
Chapter 1, The Foundation Of Pharmacology: Quality And Safety
1. A Woman Diagnosed With Obsessive–Compulsive Disorder Has Been Prescribed Oral
Paroxetine Hydrochloride. What Is The Expected Effect For This Prescription?
A. Curative Effect On Symptoms
B. Systemic Effect On Symptoms
C. Local Effect On Symptoms
D. Parenteral Effect On Symptoms
ANSWER; B
Rationale: Drugs That Produce Systemic Effects Are Taken Into The Body, Circulated Through
The Bloodstream To Their Sites Of Action In Various Body Tissues, And Eventually Eliminated
From The Body. Curative Agents Are Given To Cure A Disease Process. In This Case, Paroxetine
Hydrochloride Will Control The Symptoms But Not Cure The Disorder. Drugs With Local Effects,
Such As Sunscreen And Local Anesthetics, Act Mainly At The Site Of Application. Paroxetine
Hydrochloride Is Not Administered Parenterally. Parenteral Agents Are Administered
Subcutaneously, Intramuscularly, Or Intravenously.
PTS: 1 REF: P. 3, Introduction OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological And Parenteral Therapies TOP:
Chapter: 1: The Foundation Of Pharmacology: Quality And Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
2. A Client Has Been Prescribed An Antibiotic. This Medication Is A Naturally Occurring
Substance That Has Been Chegmricaaldlyemsobdoifoiesd.TW.Hcaot Mis Another Name For This
Type Of Medication?
A. Synthetic Drug
B. Semisynthetic Drug
